The structure of the core in restrictocin closely resembles thai in RNase Tl suggesting that they have similar catalytic mechanisms. However, restrictocin contains long connecting loops which have been proposed to be important for the unique substrate specificity of this protein. The docking model of the NMR structure of a 29-mer RNA substrate analog with restrictocin crystal structure has indicated that structural elements involved in RNA substrate binding include a landing platform comprising of loops L2 (aa 36-48) and a lysine rich loop L4 (aa 99-117), and a positively-charged ridge in loop domain L3 (aa 53-91) (Yang and Moffat, 1996).
ribonuclease, and have postulated that the specificity of ribotoxins are the result of natural genetic engineering in which the ribosomal targeting elements of ribosomeassociated proteins were inserted into non-essential regions of T1-like ribonucleases.
Based on structural and sequence homology studies Tyr 47, His 49, Glu 95, Phe 96, Pro 97, Arg 120 and His 136 have been proposed to be in the active site of restrictocin (Martinez del Pozo et a!., 1988; Yang and Moffat, 1996) . We have shown that Tyr 4 7
and His 49 are involved in the target recognition, and Glu 95, Arg 120 and His 136 in catalytic activity of restrictocin (this study chapter II). However, Phe 96 and Pro 97 do not appear to be involved in catalysis by restrictocin. Earlier, mutation of His 136 in restrictocin and His 137 in a-sarcin have been shown to completely inactivate the toxins (Yang and Kenealy, 1992; Lacadena et al., 1995) , whereas mutation of Glu 95 in restrictocin rendered the toxin partially inactive (Yang and Kenealy, 1992) . Kao and co-workers have carried out chemical mutagenesis in mitogillin, and shown that His 49, Glu 95, Arg 120 and His 136 are important for catalysis by the toxin (Kao et al., 1998) .
The ribotoxins have great potential to be utilized for construction of immunotoxins. Immunoconjugates and chimeric toxin have been made with restrictocin that have been found to be active on various tumor cell lines (Rathore and Batra, 1996; Rathore and Batra, 1997b ) . In the construction of chimeric toxins, a small toxin is desirable as it provides better penetration into the target cells, lower antigenecity in the foreign host and better folding of the chimeric molecule. To obtain the smallest biologically active derivative of a protein, it is important to map and localize the functional activity in the molecule.
In the current study an attempt was made to localize region(s)/domain(s) in restrictocin essential for its catalytic activity. In order to achieve this, the available information on the essential amino acid residues as well as the result of the studies mentioned in Chapter-! and Chapter-II were taken into consideration and systematic deletions of amino acid residues from both the termini were carried out. Three Nterminal deletions removing 8, 15 and 30 amino acids and four deletion mutants from the carboxyl terminus lackirg 4, 6, 11 and 14 amino acids were constructed. The deletion mutants were expressed and purified from E. coli and functionally characterized.
Localization of activity in restrictocin

EXPERIMENTAL PROCEDURES
Construction of deletion mutants of restrictocin
The plasmid containing restrictocin gene m a T7 promoter-based E. coli expression vector was used as the template to amplify the desired region of restrictocin by PCR while inserting initiation codon and termination codon at appropriate locations to construct the deletion mutants. For deleting 8, 15, and 30 amino .acids from Nterminus, fragment of restrictocin gene was amplified using 5' primers from the appropriate region containing Nde I restriction site and ATG initiation codon placed upstream of the codons for 9, 16, and 31st amino acid residue respectively with the help of PCR (Ausubel et al., 1993) . The common 3' primer, JRS-3 contained Eco RI site after the stop codon and annealed to the 3' end of restrictocin. The 5' primers SD-8, SD-15, and SD-30 were used to construct the deletion mutants ~1-8, ~1-15 and ~1-30 respectively ( amino acid residue by PCR using primers S3 'D4, S3 'D6, S3 'D 11, and S3 'D 14 respectively along with the common 5' primer XUP that anneals to the sequences upstream to restrictocin gene in the vector (Table 3 .1 ). The purified amplified fragments were digested with Nde I and Eco RI and ligated to pVex11 digested with the same enzymes. p Vex 11 is a T7 promoter-based expression vector with a bacterial and phage F1 origin of replication. The mutations were confirmed by DNA sequencing using dideoxy chain termination method (Sanger et al., 1977) . The letters in small case represent the nucleotides mutated and the underlined sequence denotes the restriction sites created in the primer.
Localization of activity in restrictocin Figure 3.1. All the three mutants lack cysteine 5 and hence lack the outer disulfide, however, they have all the known and predicted essential residues intact.
Expression and purification
The three N-terminal deletion mutants of restrictocin, ~ 1-8, ~ 1-15 and ~ 1-30, were expressed in BL21 (ADE3) strain of E. coli, and were localized in the inclusion bodies like restrictocin. The mutants were isolated and purified to homogeneity using successive cation exchange and gel filtration chromatography. The recombinant proteins from the inclusion bodies were denatured in guanidine hydrochloride and renatured in a glutathione-based refolding buffer. The renatured material after dialysis was loaded onto a S-sepharose cation exchange column. The mutants like the native toxin eluted at 0.6 M Sodium Chloride from the S-sepharose column. The relevant fractions were pooled and purified using a TSK gel filtration column to obtain the monomeric forms of the proteins. The purified preparations of mutants gave single band on SDS-PAGE (Fig 3.2A) . The size of the mutants was smaller than the native toxin corresponding to the number of amino acids deleted. All the mutants and the native toxin reacted equally well with a polyclonal antibody raised against restrictocin as shown in the Western blot (Fig 3.2B) .
CD-spectral analysis
The effect of the amino terminal deletions on the secondary structure of restrictocin was studied by far-UV CD spectral analysis of the purified mutants. The secondary structure analysis from the CD measurements were performed using Yang reference parameters (Yang et al., 1986) . The mean residue ellipticity curves of the mutants ~1-8, ~1-15 and ~1-30 have been compared with that of restrictocin ( Figure   3 .3). There were significant differences observed between the mean residue ellipticity curves of the native toxin and the deleted versions of the toxin. There was a substantial decrease in the helix content of the mutants (Table 3 .2) indicating a reduced secondary structure and among the three, ~1-8 had a relatively more compactly folded structure and A4326 to generate a 400 nucleotides long fragment from the 3' end of the large ribosomal RNA, known as a-fragment. The effect of N-terminal deletions on the specific ribonucleolytic activity of restrictocin was evaluated. Rabbit reticulocyte lysate was treated with the full length restrictocin and its truncated versions and the total RNA was isolated and analyzed on gel to detect the production of the a-fragment. The mutant ~1-8 was found to be partially active and produced the a-fragment at a much higher concentration compared to restrictocin (Figure 3 .4). ~ 1-15 and ~ 1-30 were both inactive and did not produce the a-fragment even at 100 J.Lg/ml concentration ( Figure   3 .4). Thus, removal of eight amino acid residues renders the toxin partially inactive while removal of 15 or more residues makes it completely inactive in its ribonucleolytic activity.
Effect of deletions on in vitro protein synthesis inhibitory activity of restrictocin
The ability of the restrictocin mutants to inhibit protein synthesis was tested in a rabbit reticulocyte lysate-based in vitro translation system. The lysate was treated with different concentrations of the native toxin and the deleted variants and the translation of endogenous globin mRNA was carried out. Inhibition of protein synthesis was measured as decrease in incorporation of CH] leucine in the nascent polypeptides synthesized. The amount of toxin that caused 50% inhibition of translation was termep as IDso value. The full length restrictocin caused a dose dependent inhibition of protein synthesis with an 1Dsoof8 ng/ml as shown in Figure 3 .5. The mutant ~1-8 was partially active with an IDso value of 49 ng/ml, while the mutant ~ 1-15 retained some activity and had an ID 50 value of 290 ng/ml (Table 3. 3). The mutant ~1-30 was completely inactive (Figure 3 .5 and Table 3 .3).
Cytotoxicity on HeLa cells
Restrictocin and its mutants were tested for their cytotoxic activity on HeLa cells infected with adenovirus. The decrease in incorporation of CH] leucine in the newly synthesized cellular proteins was taken as the measure of the cytotoxicity. None of the N-terminal deletion mutants showed any cytotoxic activity, while the full length toxin showed a dose dependent cytotoxicity in this assay (Figure 3 .6). The deletion Concentration, ng/ml mutants were completely inactive, as even with 100 Jlg/ml they could not achieve 50%
inhibition as compared to the native toxin which had an ID 50 of 2 Jlg/ml (Table 3 .4).
Deletion of amino acid residues from C-terminus of restrictocin
Construction of C-terminal deletion mutants of restrictocin
Four mutants ~146-149, ~144-149, ~139-149, ~136-149 were constructed, which respectively have 4, 6, 11 and 14 amino acids deleted from the carboxyl end of restrictocin. The deletions were made by PCR using restrictocin gene as the template and a stop codon was incorporated after appropriate amino acid residues. The deletions and incorporation of stop codon were confirmed by DNA sequencing. All the deletion mutants thus made lack Cys 147 and hence the Cys 5-Cys 147 disulfide is missing in all of them (Figure 3 .7). In ~136-149, His 136 is deleted, however, in .the rest of the mutants all residues known to be involved in catalysis are present.
Expression and purification of C-terminal deletion mutants
The four C-terminal deletion mutants ~146-149, ~144-149, ~139-149 and ~ 136-149 of restrictocin were expressed in E. coli and found to accumulate in the inclusion bodies like the native toxin. The recombinant proteins were purified to homogeneity using successive cation-exchange and gel filtration chromatography as the carboxyl terminus also resulted in a major alteration of the secondary structure of the toxin (Figure 3.9) .
Specific ribonucleolytic activity of C-terminal deletion mutants of restrictocin
The ability of the carboxyl terminal deletion mutants of restrictocin to specifically cleave the 28S ribosomal RNA was evaluated using rabbit reticulocyte lysate. The mutant ~146-149, with the smallest deletion of 4 amino acid residues, was partially active and produced a faint a-fragment at a higher concentration compared to restrictocin (Figure 3 .10). The deletion mutants ~ 139-149 and ~ 144-149 failed to cleave the ribosomal RNA even at ten times higher concentration than the native toxin (Figure 3 .10). As expected, the mutant ~ 136-149 that had lost the critical residue His 136 was inactive and had no visible ribonuclease activity (Figure 3.1 0) .
Activity of the C-terminal deletion mutants on in vitro protein synthesis_
The impact of the various deletions from the carboxyl terminus of restrictocin on the ability of the toxin to inhibit protein synthesis in vitro was tested in a rabbit reticulocyte lysate-based in vitro translation system (Figure 3 .11 ). The native toxin
showed an ID 50 value of 8 ng/ml, while the mutant ~ 146-149 was about three times less active with an IDso value of 23 ng/ml (Table 3 .6). The mutants ~136-149, ~139-149 and ~144-149 were completely inactive showing no inhibition upto 1000 ng/ml (Table   3 .6).
Cytotoxic activity of C-tenninus deletion mutants on HeLa cells
HeLa cells were infected with adenovirus and treated with the full length and Cterminal truncated versions of restrictocin to evaluate their cytotoxic ability. All of the C-terminal truncated versions showed very.poor cytotoxic activity similar to the control mutant ~ 136-149 (Figure 3.12) . As compared to an ID 50 of 2 J.Lg/ml for the native toxin, the deleted versions showed no inhibition of cellular protein synthesis even at I 00 J.Lg/ml (Table 3.7) .
DISCUSSION
The study shows that deletion of eight amino acids from the N-terminus or four amino acids from the C-terminus render the toxin partially inactive. Any further deletions from either ends resulted in the total inactivation of the toxin. ~J -8 and ~I 46- does not ap'pear to be an outcome of the absence of DS-I.
In this study, deletions have been done from either amino or carboxyl-terminus of restrictocin in order to map the active domain and also investigate the importance of the termini in the function of the toxin. All the deletion mutants except for the Cterminus deletion mutant ~ 136-149 that had lost His 136, a residue known to be involved in catalysis, had all the putative active site residues intact. The loss of activity observed appears to be a reflection of structural perturbations. The deletions made in the current study that retain the partial activity of the toxin are deletions that remove partly ~ 1 (~ 1-8) and ~7 (~ 146-149) respectively from the amino and carboxyl ends of restrictocin. Further deletions from the N-terminus deleting ~ 1 +L1 (~ 1-15) and ~ 1, -30) or from C-terminus totally deleting ~7 (~144-149) and ~7+L6 (~139-149) apparently produce a total collapse of restrictocin structure. Kao and Davies . ( 1999) have proposed that there is hydrogen bond formation between amino acid residues in ~I and ~2 with residues in ~6 and hence deletion of residues from this region causes loss of catalytic activity of mitogillin. The loss of restrictocin function arising out of the small deletions made in this study may possibly be due to the collapse of such hydrogen bonded links that usually contribute to maintaining an active conformation even in the absence of the outer disulfide bond. It is quite evident that the amino acid sequences at both ends of restrictocin are extremely crucial in maintaining an enzymatically active conformation of the toxin. The C-terminus seems relatively more crucial than the N-terminus as comparatively smaller deletions on the carboxyl end make the toxin partially inactive.
The role of the termini in the structure and function of different ribonucleases has been studied quite extensively. The amino terminal sequence of bovine RNase A known as S-peptide, consisting of 20 amino acid residues, contributes to the maintenance of the structure of the rest of the molecule called S-protein (Doscher and Localization of activity in restrictocin Hirs, 1967) . The side chain of Phe 8 in S-peptide has been found to contribute to the stabilization of the transition state of the complex between S-peptide and S-protein that gives rise to the stability of RNase S (Goldberg and Baldwin, 1999) . A deletion of 7 amino acid residues from the amino terminal end of human pancreatic ribonuclease destabilizes the folded structure of the RNase molecule and the truncated molecule was found to retain some ribonuclease as well as RNase inhibitor binding ability (Futami et al., 1995) . The carboxyl terminal end tetrapeptide sequence EDST has peen found not to be essential for the ribonuclease activity of human pancreatic ribonuclease but the deletion of the four amino acids seems to increase the thermal stability of the enzyme (Bal and Batra, 1997). The C-terminal EDST extension in human pancreatic ribonuclease has been proposed to be destabilizing the C-terminal helix and that its deletion may facilitate efficient folding of the molecule (Bal and Batra, 1997). It appears that both the N and C termini in restrictocin are contributing towards the folding of the molecule to attain an active conformation.
In conclusion, the current study has shown that an intact amino and carboxyl terminus is extremely crucial for retaining the enzymatically active conformation of restrictocin. Although the putative active site residues of this unique ribonuclease are quite far from both the termini, and an intact Cys 5-Cys 147 disulfide bond connecting the two termini is not essential for its activity, yet the two termini seem to play an important role in maintaining its functionally active conformation.
